ABCC4 and acute coronary syndrome: Platelet molecular analysis demonstrated increased MRP4 expression compared with aspirin-treated patients without acute coronary syndromes, suggesting impaired aspirin responsiveness consistent with a high-on-aspirin residual platelet reactivity phenotype.